Rockbridge Investment Management’s PAVmed PAVM Stock Holding History

Rockbridge Investment Management’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1	Closed	-$112	–	480
2023 Q4	$112	Buy	+1	New	+$118	﹤0.01%	653

Other funds holding PAVM

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rockbridge Investment Management's PAVM Position: Q1 2024 in Review

Rockbridge Investment Management sold out of PAVmed (PAVM) in Q1 2024, closing a stake of 1 share — an estimated $112 sold.

Rockbridge Investment Management first reported a position in PAVM in Q4 2023 and held it in 1 quarter. The position peaked at $112 in Q4 2023. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2024.

Rockbridge Investment Management reported no remaining PAVmed position as of Q1 2024 after selling out during the quarter.
Rockbridge Investment Management sold 1 PAVmed share in Q1 2024, an estimated $112.
Rockbridge Investment Management first reported a position in PAVmed in Q4 2023 and held it in 1 quarter.
Rockbridge Investment Management's PAVmed position peaked at $112 in Q4 2023.
20 funds tracked by Wall St. Rank held PAVmed as of Q1 2024.

Based on Rockbridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.